Related references
Note: Only part of the references are listed.Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond
Jesus Garcia-Lopez et al.
TRENDS IN GENETICS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Christopher R. Merritt et al.
NATURE BIOTECHNOLOGY (2020)
ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies
Anna Pamela Calinawan et al.
PROTEOMICS (2020)
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
Jamie Zagozewski et al.
NATURE COMMUNICATIONS (2020)
Response to trametinib treatment in progressive pediatric low-grade glioma patients
Florian Selt et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Francesca Petralia et al.
CELL (2020)
Autocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma
Lakshana Sreenivasan et al.
CELL DEATH & DISEASE (2020)
Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer
Jianying Jin et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Jason Fangusaro et al.
LANCET ONCOLOGY (2019)
MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer
Mengyu Xie et al.
CANCER RESEARCH (2019)
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
Liguo Zhang et al.
CANCER CELL (2019)
Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences
Anqi Zhu et al.
BIOINFORMATICS (2019)
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
Sebastien Perreault et al.
BMC CANCER (2019)
Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap
Juri Reimand et al.
NATURE PROTOCOLS (2019)
IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells
Tiziana Notarangelo et al.
CANCER LETTERS (2018)
CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma
Lisa Liang et al.
CANCER RESEARCH (2018)
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
Laura Hueser et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W. Robinson et al.
LANCET ONCOLOGY (2018)
LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB
Eric Bouffet et al.
NEURO-ONCOLOGY (2018)
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
Nagaraj S. Nagathihalli et al.
CANCER RESEARCH (2018)
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data
Roelof J. C. Kluin et al.
BMC BIOINFORMATICS (2018)
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C. Schwalbe et al.
LANCET ONCOLOGY (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee et al.
NEURO-ONCOLOGY (2017)
Selumetinib in Plexiform Neurofibromas
Jose S. Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model
Katharine Victoria Jensen et al.
PLOS ONE (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M. G. Cavalli et al.
CANCER CELL (2017)
Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
Vijay Ramaswamy et al.
NEURO-ONCOLOGY (2016)
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy et al.
ACTA NEUROPATHOLOGICA (2016)
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Giovanni Y. Di Veroli et al.
BIOINFORMATICS (2016)
Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma
Daniel Markowitz et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
Mihaela Pertea et al.
NATURE PROTOCOLS (2016)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors
Xuesong Zhao et al.
CANCER RESEARCH (2015)
Characterization of Cancer Stem Cells and Primary Cilia in Medulloblastoma
David Gate et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Isolation and characterization of cancer stem cells from medulloblastoma
J. Liu et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes
Lisa Liang et al.
ONCOTARGET (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool et al.
CANCER CELL (2014)
The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNFα
Michael P. Smith et al.
CANCER DISCOVERY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma
Hemant K. Bid et al.
CLINICAL CANCER RESEARCH (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas
Fang Liu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes
Ludivine Coudiere Morrison et al.
NEOPLASIA (2013)
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human
Xuqun Tang et al.
CHILDS NERVOUS SYSTEM (2012)
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
Till Milde et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
In Vivo Generation of Neural Tumors from Neoplastic Pluripotent Stem Cells Models Early Human Pediatric Brain Tumor Formation
Tamra E. Werbowetski-Ogilvie et al.
STEM CELLS (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo
Susan E. Spiller et al.
BMC CANCER (2011)
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
Gerrit J. P. Dijkgraaf et al.
CANCER RESEARCH (2011)
STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17
Bingbing Dai et al.
CANCER RESEARCH (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
Braden C. McFarland et al.
MOLECULAR CANCER THERAPEUTICS (2011)
MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma
Pasqualino de Antonellis et al.
PLOS ONE (2011)
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico et al.
PLOS ONE (2010)
Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma
Tracy-Ann Read et al.
CANCER CELL (2009)
Multipotent CD15(+) Cancer Stem Cells in Patched-1-Deficient Mouse Medulloblastoma
Ryan J. Ward et al.
CANCER RESEARCH (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Transient inhibition of the hedgehog pathway in young mice causes permanent defects in bone structure
Hiromichi Kimura et al.
CANCER CELL (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Share Paper
